US EditionPublished • loading... • Updated
Novo's Double Departures: As GLP-1 Luminary Retires, an Obesity Leader Goes to Boehringer Ingelheim
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Novo Nordisk's most famous employee Lotte Bjerre Knudsen leaves the company. Lotte Bjerre Knudsen, the most famous employee of Danish pharmaceutical giant Novo Nordisk, has resigned from the company. The researcher responsible for the development of GLP-1 drugs worked for the company for 36 years and most recently held the title of Chief Scientific Advisor. She is often referred to in the media as the "mother of Ozempic." Ozempic is Novo Nordisk…
·Finland
Read Full Article
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
